Ardea Biosciences, Inc.
Ardea Biosciences, Inc. is a biotechnology company, which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. It develops small-molecule therapeutics for the treatment of human immunodeficiency virus and cancer; and product candidates for the chronic management of hyperuricemia in gout patients. The company's products are Lesinurad (RDEA594), RDEA3170 and BAY 86-9766 (RDEA119). Ardea Biosciences was founded in January 1994 and is headquartered in San Diego, CA.